A new series of chromeno-annulated cis -fused pyrano[3,4- c ]pyran derivatives have been prepared and evaluated for their anti-proliferative activity against human cancer cell lines.
No takes yet. Share an insight, caveat, or question.
Venkatesham et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: